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IN A PRELIMINARY study, the effects of ventroposterior medial pallidotomy were evaluated in five patients with 
advanced Parkinson's disease in whom medical therapy had failed. The mean age was 67.0 ± 5.6 years, and the mean 
Hoehn and Yahr stage when "off" was 3.9 ± 1.3. Three patients received unilateral pallidotomies; two of these 
received another pallidotomy after 8 weeks. Two other patients received staged bilateral pallidotomies. No 
significant differences in overall function could be seen before and after the first surgical procedure. All three 
,patients with peak-dose dyskinesias or dystonia had marked contralateral reduction in these symptoms. Ventropos-
terior medial pallidotomy can ameliorate peak-dose dyskinesias in patients with advanced Parkinson's disease. 
Overall functional improvement is not remarkable. (Neurosurgery 36:1112-1117,1995) 
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There has been a renewed interest in the surgical treat-ment of Parkinson's disease. Recent reports on the re-sults of ventroposterior medial pallidotomy suggest a 
role for this procedure in moderately severe Parkinson's dis-
ease (1, 5, 8, 9, 11, 13, 14, 16, 18). Because of these initially 
promising reports in patients with moderately severe disease, 
we undertook a pilot study to see if similar benefits could be 
obtained in patients with advanced, medically refractory Par-
kinson's disease. We report here the preliminary results of 
this procedure. 
had failed in all patients, and'most of the patients had severe '\ 
motor fluctuations with peak-dose dyskinesias or dystonia. 
(See Table 1 for baseline patient characteristics). All five pa-
tients had been treated by the investigators for at least 6 
months before enrollment in the study. The risks, the benefits, 
and the experimental nature of the procedure were outlined 
PATIENTS AND METHODS 
Patient selection 
All patients (n = 5) had advanced Parkinson's disease with 
disabling symptoms; their mean age was 67.0 ± 5.6 years, the 
mean disease duration was 11.6 ± 6.9 years, and the mean 
Hoehn and Yahr stage when "off" was 3.9 ::':: 1.3 (the average 
of two preoperative assessments). Previous medical therapy 
in detail for each patient, and their written informed consent 




Patients were evaluated 2 weeks and 1 week before sur-
gery, and 2, 4, and 8 weeks after each surgical procedure. On 
each test date, the patients were first evaluated in a practically' 
defined "off" state, with their last anti-parkinsonian medica-
tion taken at least 9 hours before the assessment. Patients then 
took their usual morning dose of levodopa, dopamine ago-
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TABLE 1. Patient Characteristics at Baseline 
Duration Medications 
Patient 
Sex of H&Y" No. Age Disease (on/off) Levodopa Pergolide Amantadine 
(yr) (mgld) (mgld) (mgld) Other (dose/d) 
1 M 69 14 1.5/2.5 1700 0.00 0 Akineton (2 mg) 
2 M 64 5 5/5 800 1.00 a Frorinef (0.3 mg) 
Zoroft (1/2 tab) 
3 F 67 4 5/5 250 0.00 0 Amitriptyline (50 mg) 
Clonazepam (12.5 mg) 
4 F 60 20 3/4.5 800 0.75 100 Paxil (20 mg) 
Trazodone (100 mg) 
5 M 75 15 2.5/2.5 950 0.75 200 Deprenyl (5 mg) 
• H&Y, Hoehn and Yahr stage; (on/off) indicates stage at times each patient was "on" or "off" (the average of two preoperative assessments). 
nists, and anticholinergic medications, and they were again 
evaluated when "on." Assessments performed both on and 
off included a complete Unified Parkinson's Disease Rating 
Scale (UPDRS) (4), Hoehn and Yahr staging (12), and the 
Schwab-England Activities of Daily Living scale (4). Subscales 
were constructed from the individual items on the UPDRS to 
analyze akinesia, rigidity, and tremor, globally as well as on 
each side of the body. A Folstein Mini-Mental Status Exami-
nation (6) and Hamilton Depression Inventory (10) were com-
pleted also at each visit. 
Timed tasks 
Timed tasks of motor performance were also performed in 
the off and on states, as described previously by Lindvall et al. 
(15). These included assessments of pronation-supination, 
hand opening and closing, fine finger movements, heel tap-
ping, and gait. 
~. Additional evaluations 
resonance imaging to choose the optimal lesion placement 
(medial globus pallidum). Each initial radiographic target was 
then chosen on intraoperative computed tomography (1-mm 
scan thickness), with the gantry parallel to the anterior com-
missural-posterior commissural (AC-PC) line. Targets were 
chosen 2 mm anterior, 19 to 22 mm lateral, and 5 mm ventral 
to the AC-PC line. The Cosman-Roberts-Wells stereotactic 
instrument (Radionics, Inc., Burlington, MA) was used for the 
electrode placement (3). Patients received intravenous injec-
tions of propofol for sedation during the placement of the 
burr hole and the lesioning electrode. A single large burr hole 
was placed 2 cm lateral to the midline just posterior to the 
coronal suture, and the monopolar electrode was inserted 
CRadionics, Inc.) (1.2-mm diameter tip with 2-mm uninsulated 
length). In each patient, ventriculography with Isovue M-200 
dye helped to confirm the electrode placement. Several lesions 
were made for each procedure, inserting the electrode deeper 
or withdrawing it by several millimeters; the final locations of 
the lesions depended on the patient's response to the electrical 
stimulation. 
Magnetic resonance imaging scans were obtained at base-
line, within 1 week after surgery, and 4 weeks after each 
surgery. Computerized visual fields were obtained before the 
first surgical procedure for three patients and after the last 
surgical procedure for all patients. Patients were videotaped 1 
week before and 4 weeks after all surgical procedures. 
Surgical technique 
Each patient underwent a unilateral pallidotomy as his or 
her initial surgical procedure. Patients 2 and 3 underwent 
repeated surgery on the same side, because early improve-
ment and subsequent relapse suggested that the initial lesions 
might have been too small in size. Patients 1 and 4 had 
subsequent contralateral pallidotomies. Patient 5 had a single 
left pallidotomy. 
For all procedures, target localizations were performed on 
. the basis of the guidelines published by Laitinen et a1. (14). 
The preoperative target was planned on thin-slice magnetic 
Intraoperative stimulation and lesioning protocol 
For each potential lesion site, stimulation was first per-
formed at low frequencies (2-5 Hz) and subsequently at 
higher frequencies (typically 50 Hz), starting with low voltage 
and increasing the voltage slowly. We paid close attention to 
any indication that a patient had visual hallucinations of 
flashing lights, which suggested that the tip of the lesioning 
electrode was too close to the optic tract. We also looked for 
evidence of clonic, tonic, or dystonic movement of the extrem-
ities or face, and we assessed for possible changes in speech. 
Then, a physiological, reversible "mock" lesion was made 
by heating the electrode tip to 42°C. In most cases, this accu-
rately predicted the response to the final anatomical lesion, 
and reversible improvement of contralateral rigidity and aki-
nesia was noted . 
A permanent anatomical lesion was made by heating the 
electrode tip to 72 to 80aC for up to 60 seconds. The electrode 
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was moved in 2-mm increments, and the lesioning process 
was repeated to increase the overall lesion size. The total 
number of repetitions of this process depended on the pa-
tient's clinical response. 
RESULTS 
In all cases, magnetic resonance imaging was used postop-
eratively to verify the size and location of the globus pallidum 
lesion. The lesions were localized in three dimensions (x, y 
and z). Postoperative studies showed that all patients had 
lesions located between 17 and 21 mm lateral to the midline 
(x) and that all but one patient had lesions between 1 and 3 
mm anterior to the midpoint of the AC-PC line (y) (Patient 2's 
lesion was 5 mID anterior). The vertical extent of the lesions on 
postoperative studies (z) varied among patients, despite the 
relatively uniform time of electrical lesioning among some 
patients in the group. The vertical extent of the lesions was 
specified as a distance, as the lesioning electrode was moved 
and multiple lesions were placed (mean, 15.2 mm). The ver-
tical lesion lengths were as follows: Patient 1, 4.5 mm, 
centered 4 mm below AC-PC line; Patient 2, 9.0 mm, cen-
tered 3 mm below the AC-PC line; Patient 3, 9 mm, centered 
3 mrn below the AC-PC line; Patient 4, 10.5 mID, centered 2 mID 
below the AC-PC line; and Patient 5, 4.5 mm, centered 
3 mm below the AC-PC line. No significant differences 




Patient I, a 69-year-old, right-handed retired professor of political 
science, had first developed Parkinson's disease 14 years before this 
surgery. His first symptoms consisted of gait difficulty and foot 
dystonia. He initially responded to levodopa, but, as hls disease 
progressed, he developed end-of-dose deterioration with bilateral 
foot dystonia, violent peak-dose dyskinesias, frequent falling caused 
by freezing, and marked deterioration of his handwriting. Trials on 
pergolide and bromocriptine had failed; by the time of hls first 
surgery, he was taking a total daily dose of 1700 mg levodopa. 
The first surgery for Patient 1 was right-sided pallidotomy. During 
surgery and immediately after surgery, observers noted marked im-
provement in left-sided foot dystOnia, rigidity, and rapid alternating 
movements. No postoperative complications were noted during the 
week after surgery, and he had improvement in akinesia, tremor, 
rigidity, and dystonia on the left side. He complained of worsened 
speech, but the results of the physical examination did not confirm 
this. Peak-dose dyskinesias were improved on the left; however, his 
balance worsened, and he continued to fall frequently. Because of 
this, he increased his levodopa dose to a total of 2100 mg daily. On 
several occasions, he hit his head. Nine weeks after surgery a mag-
netic resonance imaging scan showed a substantial right convexity 
subdural hematoma, which was drained without complication. Be-
cause his worsened balance seemed to be caused by persistent right-
foot dystonia and not to be a complication of his first surgery, he had 
a left-sided pallidotomy 11 weeks after the first pallidotomy and 2 
weeks after drainage of the subdural hematoma. 
During the left-sided pallidotomy and immediately after that sur-
gery, patient 1 showed marked improvement in contralateral brady-
kinesia and motor tasks, and his voice was stronger. His gait did not 
improve significantly after the second surgery, although his right foot 
dystonia improved moderately. Speech was unequivocally improved; 
however, shortly after the second pallidotomy, he developed a severe 
clinical depression with suicidal ideation. His Hamilton Depression 
Inventory score rose from 8 before surgery to 17 after surgery. Visual 
field testing 12 weeks after his second surgery revealed an incongru-
ent left homonymous hemianopsis that had not been noted on routine 
confrontation testing. He has increased his total daily dose of levo-
dopa to 2500 mg and now finds it difficult to distinguish on and off 
states. He falls frequently because of persistent, severe freezing. 
Patient 3 
Patient 3, a 67-year-old, left-handed former store manager, had had 
Parkinson's disease for 4 years. When she was receiving levodopa, 
she developed peak-dose dystonic spasms of her left shoulder. By the 
time of surgery, she had profound left arm rigidity and had devel-
oped a frozen left shoulder. She also had left arm resting tremor, 
marked global bradykinesia, and bilateral dystonic foot inversion; she 
could stand only with assistance. 
First, a right-sided pallidotomy was performed. Immediately after 
surgery, there was a marked improvement in left arm akinesia and 
rigidity. For the first 24 hours after surgery, a marked improvement in 
left arm mobility was observed; however, this early improvement 
diminished by the second day and disappeared completely by the 
third day after surgery. Because of the clear, although temporary, 
benefit seen on the first day after surgery, a second procedure was 
planned to enlarge the original lesion and provide a more lasting 
response. 
Eight weeks later, a second right-sided pallidotomy was per-
formed. The first of four lesions produced marked improvement in 
left-sided akinesia and rigidity, and subsequent lesions produced 
some additional incremental improvement. Finding that peak-dose 
dystonia of the left shoulder was drastically reduced over the next 
few months, the patient gradually increased her total daily levodopa 
dosage to 1800 mg with a great subjective improvement in overall 
function. Objectively, there was a marked reduction in shoulder 
dystonia. 
Patient 4 
Patient 4, a 60-year-old, right-handed former secretary, had a 20-
year history of Parkinson's disease and had been receiving levodopa 
for most of that time. By the time of her surgery, she was having 
severe fluctuations with wearing-off and unpredictable off periods. 
When on, she would have disabling, violent peak-dose dyskinesias. 
Her Hoehn and Yahr off was Stage 4.5. 
First, a right-sided pallidotomy was performed. Immediately after 
surgery, there was improved tone in the left arm and leg, with no 
complications. Peak-dose dyskinesias were essentially abolished on 
the left side of her body. Her Hoehn and Yahr stage, when off, 
improved from her preoperative stage 4.5 to stage 3, her stage when 
on improved from her preoperative stage 3 to stage 2. By 4 weeks 
after being discharged, she was doing much better. On time had 
increased, and off periods were shorter in duration and less frequent. 
Pergolide was increased to 1.5 mg a day. Some akathisia persisted, 
however. By 8 weeks after surgery, persistent right-sided dyskinesias 
were throwing the patient off balance when on. Because of her excel-
lent response to the initial pallidotomy, and because her residual 
right-sided dyskinesias appeared to be the main cause for her ongo-
ing disability, she was scheduled for contralateral pallidotomy. 
Second, a left-sided pallidotomy was performed. During surgery 
and immediately after surgery, there was a significant decrease in 
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tone in the right arm and leg. By the first postoperative day, there was 
a dramatic reduction in dyskinesia, and there appeared to be im-
provement in speech. Transient blurred vision in the right eye was 
noted; subsequently, formal visual field testing revealed a new deficit 
in the right superior quadrant. Depression was noted before she was 
discharged from the hospital, and, by 4 weeks after the surgery, the 
patient's score on Item 3 of the UP DRS, an indication of depression, 
had worsened from a score of 1 to 4. 
Parkinson Rating Scale (all patients) 
No differences were seen between the preoperative and 
postoperative results in either the mean UP DRS scores, or any 
of the traditional three subdivisions (mentation, activities of 
daily living [on or off], or motor examination [on or off]). 
Specific subscales were constructed to assess the following 
areas, both on and off: gait/posture, right-sided akinesia, 
left-sided akinesia, right-sided tremor, left-sided tremor, 
right-sided rigidity, and left-sided rigidity. Again, there were 
no differences between mean scores before and after surgery, 
either ipsilaterally or contralaterally. Timed tasks were nor-
Inalized by taking the reciprocal of the time to complete a 
task, and additional hemibody subscales were constructed. 
No significant differences were observed before or after sur-
gery in any areas, nor were any differences seen in the mean 
Schwab and England disability scores (on or off), the mean 
Hoehn and Yahr stages (on or off), or the mean Hamilton 
Depression Inventory scores (on or off) before and after uni-
lateral pallidotomy. 
Postoperative morbidity 
Morbidity after unilateral ventroposterior medial pal-
lidotomy included postoperative worsening of preexisting 
depression (n = 2), new visual field defects detected only on 
formal testing (n = 2), increased gait freezing (n = 1), wors-
ened speech (n = 1), possibly worsened swallowing (n = 1), 
and transient facial weakness (n = 2). Both patients with 
depression had evidence of long-standing depression before 
any surgical intervention. Their depression may have been 
triggered by unmet expectations of surgery, rather than by 
any surgically created structural lesion. 
DISCUSSION 
The improvement in dyskinesias in Patients 1 and 4 and the 
improvement in dystonia in Patient 3 are consistent with 
previous reported experiences. Even in the years before levo-
dopa was established as the standard treatment of Parkin-
son's disease, before the clinical syndrome of levodopa-in-
duced peak-dose dyskinesias became endemic in the 
parkinsonian population, pallidotomy was investigated in the 
treatment of other choreiform and hemiballistic movements, 
'With documented efficacy (7, 17). More recently, other inves-
tigations have confirmed the effectiveness of pallidotomy in 
ameliorating hyperkinetic choreiform movements (2). Laiti-
nen et al. (14) found a significant number of his patients had 
improvement in "dystOnia/pain" and mentions that "pal-
lidotomy had a very good effect on involuntary movement." 
m w 
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More recently, others have confirmed the dramatic effect of 
pallidotomy on peak-dose dyskinesias (I, 5, 9, 18). 
Microelectrode recording may allow better anatomical and 
physiological localization of the appropriate target, as well as 
more precise definition of the boundary between the medial 
globus pallidus and the optic tract. Pallidotomy with micro-
electrode recording might therefore reduce the incidence of 
visual field deficits. Early reports from centers using this 
technique do not mention any field deficits, suggesting a 
possible advantage of this technique (5, 16, 18). More signifi-
cantly, a clearer definition of the boundaries between the 
medial globus pallid us and either the optic tract or the inter-
nal capsule might allow a larger lesion to be created with a 
greater margin of safety, thus allowing for greater functional 
improvement. 
CONCLUSIONS 
Ventroposterolateral pallidotomy can reduce or abolish 
contralateral peak-dose dyskinesia or dystonia in selected 
patients with Parkinson's disease. In at least one patient in the 
present study, we saw a dramatic improvement in the Hoehn 
and Yahr score, suggesting that this procedure has great 
potential. However, the benefit varies among patients, and the 
risks include visual field deficits and possible depression. The 
functional improvement in patients with advanced Parkin-
son's disease was not significant. 
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COMMENTS 
This article by Sutton et a1. studies the effects of ventropos-
terior medial pallidotomy after nine procedures in patients 
with advanced Parkinson's disease. The results of the proce-
dure on many manifestations of the disease were not spectac-
ular and were variable, as the authors clearly show. In addi-
tion, patients with advanced Parkinson's disease do not do 
well with any type of ablative surgery. Interestingly, the only 
objective improvement was on levodopa-induced dyskineSia. 
Thalamotomy also decreases levodopa-induced dyskineSia, 
as has been established by the experience of many stereotactic 
surgeons. However, one will not find much in the literature 
about this because the complications of thalamotomy in pa-
tients with advanced Parkinson's disease are unacceptably 
high. In addition, bilateral thalamotomy procedures are un-
likely to be considered in this group of patients because the 
risks for speech and gait abnormalities are unacceptable. 
Ventroposterior medial pallidotomy may be more appro-
priate in less advanced bradykinetic patients who must take 
levodopa/ carbidopa for severe bradykinesia but are unable to 
do so because of severe, bilateral, drug-induced dyskinesia. 
The advantage of the pallidotomy procedure over thalamot-
omy is that complications for a staged bilateral pallidotomy 
are within acceptable levels. The authors, quite correctly, are 
distressed over the number of postoperative visual field def-
icits (usually an inferior quadranopsia, which can be bother-
some to a functional individual); I agree with the authors that 
incorporation of a microelectrode recording technique may 
reduce the incidence of this complication. 
Patrick J. Kelly 
New York, New York 
The value of using ventroposterior medial pallidotomy for 
the relief of parkinsonian bradykinesia has grasped the imag-
ination of the neuroscientific community. Although the sug-
gestion has been made that pallidotomy in a particular part of 
medial pallidum is particularly effective for the relief of bra-
dykinesia, it seems to this observer that the lesions made are 
large enough to destroy most of the medial pallidum in the 
sagittal plane in which they are done. Such destruction would 
be at odds with the suggestion that the choice of a particular 
portion of the medial pallidum in modern pallidotomy makes 
it more effective for the relief of bradykineSia than were 
standard pallidotomies done in the past. In fact, inspection of 
outcome data from the early years of stereotactic surgery 
suggests that there was improvement of a modest degree in 
bradykinetic features, improvement that would now be 
masked by levodopa therapy (1). Relief of levodopa-induced 
dyskinesia by pallidotomy is, however, quite striking; such 
dyskinesia did not exist, of course, at the time that pal-
lidotomy was popular, and the degree of relief is clearly 
greater than that achieved by thalamotomy. It still remains to 
be determined which features of parkinsonian bradykinesia 
are improved by pallidotomy and to what extent they are 
improved in the long term. Such assessment may require a 
relatively large database because the degree of improve-
ment is modest and possibly selective for certain aspects of 
bradykinesia. 
Ronald R. Tasker 
Toronto, Ontario, Canada 
1. Riechert T: Long-term follow-up of results of stereotaxic treat-
ment in extrapyramidal disorders. Confin Neurol 22:356-363, 
1962. 
The history of pallidotomy is replete with inconsistent re-
sults. The experience of Dr. Sutton et a1. is typical of that of 
several centers that have recently attempted posterior ventral 
pallidotomy. They have seen some improvements in parkin-
sonian symptoms but have given up the procedure after 
inconsistent results and complications in a few patients. 
In most instances, this repetition of history is a result of not 
being able to identify the optimal target, which appears to be 
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the sensorimotor segment of globus pallidus interna. Most of 
the time, the lesion is placed too anterior and is made too 
small. The transient improvement from a too anterior lesion 
was first reported by Spiegel and Wycis (1), who were able to 
improve their results by making a second lesion more poste-
riorly. We use the same initial targeting procedure as the 
authors and are consistently off the ideal target (as defined 
phYSiologically) by 2 mm in the x or y axis. We generally make 
two lesion tracts in the same parasagittal plane, 3 mm apart 
and equidistant from the optimal trajectory, in order to in-
clude all the adjacent sensorimotor area. In special cases, it 
may be necessary to include an additional lesion tract, either 
one more lateral for problems with the arm or one more 
medial for problems with the leg. 
The use of microelectrodes can help in identifying the cor-
ticospinal tract and optic tract and theoretically could de-
crease the complication rate. The sensorimotor area can be 
identified with true micro electrode recordings by virtue of the 
kinesthetic and tremor-associated neurons (2). One additional 
aspect concerning the authors' lesions is the height of those 
lesions; the vertical extent of globus pallidus interna is be-
tween 4 and 7 mm. With the acute angle used by these 
authors, and the rather long vertical lesioning tracts, the 
globus pallidus externa was undoubtedly included within the 
lesion. Experimental studies and our clinical investigations 
would suggest that lesioning of globus pallidus externa might 
result in worsening of symptoms, especially if the lesion in the 
r 
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globus paUidus interna is incomplete. The lesion size, in part, 
is related to duration of heating; in several of these lesions, a 
time of 15, 20, or 30 seconds was used (personal communica-
tion), and this may be insufficient to produce a large enough 
lesion. 
In order to maximize the symptomatic improvement by 
posterior ventral pallidotomy, our group believes that it is 
essential to define completely the sensorimotor region of the 
globus pallid us interna and the lesion. Our results show sig-
nificant improvement of all symptoms of Parkinson's disease, 
as well as of drug-induced dyskinesias. In no situation is this 
a cure, but the improvements in the activities of daily living 
can be substantial. Lesioning should be restricted to idio-
pathic Parkinson's as Parkinson-plus patients do not seem to 
be able to take advantage of the motoric improvement. A 
randomized clinical trial is under way at our institution to 
determine the effectiveness and safety of posterior ventral 
pallidotomy. 
Roy A.E. Bakay 
Atlania, Georgia 
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